CYTOKINETICS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cytokinetics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q2 2024.
  • Cytokinetics Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $24.6M, a 31.9% increase year-over-year.
  • Cytokinetics Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $84.4M, a 39.5% increase year-over-year.
  • Cytokinetics Inc annual Share-based Payment Arrangement, Expense for 2023 was $72.1M, a 50.6% increase from 2022.
  • Cytokinetics Inc annual Share-based Payment Arrangement, Expense for 2022 was $47.9M, a 78.3% increase from 2021.
  • Cytokinetics Inc annual Share-based Payment Arrangement, Expense for 2021 was $26.8M, a 52.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $84.4M $24.6M +$5.95M +31.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $78.5M $21.6M +$6.4M +42.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $72.1M $19.5M +$6.04M +44.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $66M $18.7M +$5.5M +41.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $60.5M $18.7M +$6.47M +53% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $54.1M $15.2M +$6.2M +68.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $47.9M $13.5M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $13.2M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $12.2M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $9M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2017 $9.03M $2.53M +$682K +36.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 $8.35M $2.4M +$500K +26.3% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $7.85M $2.2M +$400K +22.2% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-04
Q1 2017 $7.45M $1.9M +$300K +18.8% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $7.15M $1.85M +$479K +35% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-05
Q3 2016 $6.67M $1.9M +$800K +72.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $5.87M $1.8M +$600K +50% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $5.27M $1.6M +$700K +77.8% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $4.57M $1.37M +$537K +64.7% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-05
Q3 2015 $4.03M $1.1M +$200K +22.2% Jul 1, 2015 Sep 30, 2015 10-Q/A 2016-12-15
Q2 2015 $3.83M $1.2M +$300K +33.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $3.53M $900K +$200K +28.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $3.33M $830K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-06
Q3 2014 $900K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $900K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $700K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.